EDCTP commits EUR 34M to TB vaccine clinical trials
True to the World Tuberculosis Day 2018 theme ‘Wanted: Leaders for a TB-free world’, the European Union and European member states continue to take an important role in fighting this disease. Recently, the European & Developing Countries Clinical Trials Partnership (EDCTP) committed EUR 34 million in funding for four clinical trials on TB vaccines.
This is the largest European investment into clinical development of TB vaccines to date, and boosts the European and its partner’s commitment to combat one of the world’s most devastating diseases. The trials will be conducted by research institutions from sub-Saharan Africa, Europe and India.